Increased Maternal Serum Interleukin-6 Concentrations at 11 to 14 Weeks of Gestation in Low Risk Pregnancies Complicated with Gestational Diabetes Mellitus: Development of a Prediction Model

Hormone and Metabolic Research

Volumn 48, Issue 1, 2015, Pages 35-41

  Hassiakos, D ^a   Eleftheriades, M ^b,c,d,f   Papastefanou, I ^d   Lambrinoudaki, I ^a   Kappou, D ^d   Lavranos, D ^c   Akalestos, A ^e   Aravantinos, L ^a   Pervanidou, P ^d   Chrousos, G ^d  

^a UNIVERSITY OF ATHENS   (Greece)

^b EmbryoCare   (Greece)

^c BIOIATRIKI HEALTHCARE GROUP   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e Roche Diagnostics (Hellas) SA   (Greece)

^f Fetal Medicine Unit   (Greece)

Author keywords

cytokine; first trimester; gestational diabetes mellitus; IL 6; prediction model; screening

Indexed keywords

GLUCOSE BLOOD LEVEL; IL6 PROTEIN, HUMAN; INTERLEUKIN 6;

BIOLOGICAL MODEL; BIRTH WEIGHT; BLOOD; CASE CONTROL STUDY; DIAGNOSTIC IMAGING; ECHOGRAPHY; FALSE POSITIVE RESULT; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; METABOLISM; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; RISK FACTOR;

BIRTH WEIGHT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FALSE POSITIVE REACTIONS; FEMALE; GESTATIONAL AGE; GLUCOSE TOLERANCE TEST; HUMANS; INTERLEUKIN-6; MODELS, BIOLOGICAL; PREGNANCY; PREGNANCY OUTCOME; RISK FACTORS; ULTRASONOGRAPHY;

EID: 84948121635     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0034-1395659     Document Type: Article

References (42)

1. Catalano P. M., McIntyre H. D., Cruickshank J. K., McCance D. R., Dyer A. R., Metzger B. E., Lowe L. P., Trimble E. R., Coustan D. R., Hadden D. R., Persson B., Hod M., Oats J. J. HAPO Study Cooperative Research Group The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care: 2012; 35 780 786
2. Wendland E. M., Torloni M. R., Falavigna M., Trujillo J., Dode M. A., Campos M. A., Duncan B. B., Schmidt M. I. Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth. 2012; 12 23
3. Metzger B. E. Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring. Clin Obstet Gynecol: 2007; 50 972 979
4. Harreiter J., Dovjak G., Kautzky-Willer A. Gestational diabetes mellitus and cardiovascular risk after pregnancy. Womens Health (Lond Engl): 2014; 10 91 108
5. Crowther C. A., Hiller J. E., Moss J. R., McPhee A. J., Jeffries W. S., Robinson J. S. Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med: 2005; 352 2477 2486
6. Nicolaides K. H. Turning the pyramid of prenatal care. Fetal Diagn Ther: 2011; 29 183 196
7. Ferreira A. F., Rezende J. C., Vaikousi E., Akolekar R., Nicolaides K. H. Maternal serum visfatin at 11-13 weeks of gestation in gestational diabetes mellitus. Clin Chem: 2011; 57 609 613
8. Nanda S., Savvidou M., Syngelaki A., Akolekar R., Nicolaides K. H. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11-13 weeks. Prenat Diagn: 2011; 31 135 141
9. Savvidou M., Nelson S. M., Makgoba M., Messow C. M., Sattar N., Nicolaides K. First-trimester prediction of gestational diabetes mellitus: examining the potential of combining maternal characteristics and laboratory measures. Diabetes: 2010; 59 3017 3022
10. Eleftheriades M., Papastefanou I., Lambrinoudaki I., Kappou D., Lavranos D., Akalestos A., Souka A. P., Pervanidou P., Hassiakos D., Chrousos G. P. Elevated placental growth factor concentrations at 11-14weeks of gestation to predict gestational diabetes mellitus. Metabolism: 2014; 63 1419 1425
11. Gomes C. P., Torloni M. R., Gueuvoghlanian-Silva B. Y., Alexandre S. M., Mattar R., Daher S. Cytokine levels in gestational diabetes mellitus: a systematic review of the literature. Am J Reprod Immunol: 2013; 69 545 557
12. Miehle K., Stepan H., Fasshauer M. Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol (Oxf): 2012; 76 2 11
13. Sarvas J. L., Khaper N., Lees S. J. The IL-6 Paradox: Context Dependent Interplay of SOCS3 and AMPK. J Diabetes Metab: 2013; 13 http://dx.doi.org/10.4172/2155-6156.S13-003
14. Senn J. J., Klover P. J., Nowak I. A., Mooney R. A. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes: 2002; 51 3391 3399
15. Kumar P. A., Chitra P. S., Lu C., Sobhanaditya J., Menon R. Growth hormone (GH) differentially regulates NF-kB activity in preadipocytes and macrophages: implications for GH's role in adipose tissue homeostasis in obesity. J Physiol Biochem: 2014; 70 433 440
16. Tsigos C., Papanicolaou D. A., Kyrou I., Defensor R., Mitsiadis C. S., Chrousos G. P. Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab: 1997; 82 4167 4170
17. Kim J. H., Bachmann R. A., Chen J. Interleukin-6 and insulin resistance. Vitam Horm: 2009; 80 613 633
18. Atègbo J. M., Grissa O., Yessoufou A., Hichami A., Dramane K. L., Moutairou K., Miled A., Grissa A., Jerbi M., Tabka Z., Khan N. A. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab: 2006; 91 4137 4143
19. Morisset A. S., Dubé M. C., Côté J. A., Robitaille J., Weisnagel S. J., Tchernof A. Circulating interleukin-6 concentrations during and after gestational diabetes mellitus. Acta Obstet Gynecol Scand: 2011; 90 524 530
20. Bari M. F., Weickert M. O., Sivakumar K., James S. G., Snead D. R., Tan B. K., Randeva H. S., Bastie C. C., Vatish M. Elevated soluble CD163 in gestational diabetes mellitus: secretion from human placenta and adipose tissue. PLoS One: 2014; 9 e101327
21. HAPO Study Cooperative Research Group Metzger B. E., Lowe L. P., Dyer A. R., Trimble E. R., Chaovarindr U., Coustan D. R., Hadden D. R., McCance D. R., Hod M., McIntyre H. D., Oats J. J., Persson B., Rogers M. S., Sacks D. A. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med: 2008; 358 1991 2002
22. Papastefanou I., Souka A. P., Pilalis A., Eleftheriades M., Michalitsi V., Kassanos D. First trimester prediction of small- and large-for-gestation neonates by an integrated model incorporating ultrasound parameters, biochemical indices and maternal characteristics. Acta Obstet Gynecol Scand: 2012; 91 104 111
23. Souka A. P., Papastefanou I., Pilalis A., Michalitsi V., Panagopoulos P., Kassanos D. Performance of the ultrasound examination in the early and late third trimester for the prediction of birth weight deviations. Prenat Diagn: 2013; 33 915 920
24. NICE Diabetes in pregnancy: management of diabetes and its complications from pre-conception to the postnatal period. National Institute for Health and Clinical Excellence, Clinical Guideline: 2008; 63
25. Graves D. T., Kayal R. A. Diabetic complications and dysregulated innate immunity. Front Biosci: 2008; 13 1227 1239
26. Elmarakby A. A., Sullivan J. C. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther: 2012; 30 49 59
27. Rotter V., Nagaev I., Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem: 2003; 278 45777 45784
28. Lain K. Y., Daftary A. R., Ness R. B., Roberts J. M. First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin Endocrinol (Oxf): 2008; 69 407 411
29. Kuzmicki M., Telejko B., Szamatowicz J., Zonenberg A., Nikolajuk A., Kretowski A., Gorska M. High resistin and interleukin-6 levels are associated with gestational diabetes mellitus. Gynecol Endocrinol: 2009; 25 258 263
30. Kuzmicki M., Telejko B., Zonenberg A., Szamatowicz J., Kretowski A., Nikolajuk A., Laudanski P., Gorska M. Circulating pro- and anti-inflammatory cytokines in Polish women with gestational diabetes. Horm Metab Res: 2008; 40 556 560
31. Nergiz S., Altlnkaya O. S., Küçük M., Yüksel H., Sezer S. D., Kurt Ömürlü I., Odaba͆l A. R. Circulating galanin and IL-6 concentrations in gestational diabetes mellitus. Gynecol Endocrinol: 2014; 30 236 240
32. Lappas M., Permezel M., Rice G. E. Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J Clin Endocrinol Metab: 2004; 89 5627 5633
33. Kleiblova P., Dostalova I., Bartlova M., Lacinova Z., Ticha I., Krejci V., Springer D., Kleibl Z., Haluzik M. Expression of adipokines and estrogen receptors in adipose tissue and placenta of patients with gestational diabetes mellitus. Mol Cell Endocrinol: 2010; 314 150 156
34. Winzer C., Wagner O., Festa A., Schneider B., Roden M., Bancher-Todesca D., Pacini G., Funahashi T., Kautzky-Willer A. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care: 2004; 27 1721 1727
35. Retnakaran R., Qi Y., Sermer M., Connelly P. W., Hanley A. J., Zinman B. Beta-cell function declines within the first year postpartum in women with recent glucose intolerance in pregnancy. Diabetes Care: 2010; 33 1798 1804
36. Thorand B., Baumert J., Kolb H., Meisinger C., Chambless L., Koenig W., Herder C. Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Diabetes Care: 2007; 30 854 860
37. Cardellini M., Andreozzi F., Laratta E., Marini M. A., Lauro R., Hribal M. L., Perticone F., Sesti G. Plasma interleukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians. Diabetes Metab Res Rev: 2007; 23 141 145
38. Bastard J. P., Jardel C., Bruckert E., Blondy P., Capeau J., Laville M., Vidal H., Hainque B. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab: 2000; 85 3338 3342
39. Li N., Liu E., Guo J., Pan L., Li B., Wang P., Liu J., Wang Y., Liu G., Baccarelli A. A., Hou L., Hu G. Maternal prepregnancy body mass index and gestational weight gain on pregnancy outcomes. PLoS One: 2013; 8 e82310
40. Lovati E., Beneventi F., Simonetta M., Laneri M., Quarleri L., Scudeller L., Albonico G., Locatelli E., Cavagnoli C., Tinelli C., Spinillo A., Corazza G. R. Gestational diabetes mellitus: including serum pregnancy-associated plasma protein-A testing in the clinical management of primiparous women? A case-control study. Diabetes Res Clin Pract: 2013; 100 340 347
41. Beneventi F., Simonetta M., Lovati E., Albonico G., Tinelli C., Locatelli E., Spinillo A. First trimester pregnancy-associated plasma protein-A in pregnancies complicated by subsequent gestational diabetes. Prenat Diagn: 2011; 31 523 528
42. Husslein H., Lausegger F., Leipold H., Worda C. Association between pregnancy-associated plasma protein-A and gestational diabetes requiring insulin treatment at 11-14 weeks of gestation. J Matern Fetal Neonatal Med: 2012; 25 2230 2233